Dr. Jason Mouabbi's BREAKTHROUGH Discovery for Invasive Lobular Breast Cancer | OncoDaily

Dr. Jason Mouabbi from MD Anderson Cancer Center shares groundbreaking insights on invasive lobular carcinoma, a subtype of breast cancer. He discusses the tumor's immune-enriched microenvironment, highlighting potential for immunotherapy, and its highly vascularized nature, suggesting anti-angiogenesis treatments as promising therapeutic options.

Abstract:- https://doi.org/10.1200/JCO.2024.42.1...

#BreastCancer #InvasiveLobularCarcinoma #CancerResearch #MDAnderson #Immunotherapy #Angiogenesis #CancerTreatment #Oncology #TumorMicroenvironment #CancerBreakthrough #LobularBreastCancer #NovelTherapies #CancerImmunotherapy #CancerAwareness #BreastCancerResearch #OncoDaily #CancerScience #VascularTargeting #MedicalInnovation #CancerCare

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”